Aethlon Medical, Inc.
(NASDAQ : AEMD)

( )
AEMD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -2.99%576.911.0%$828.43m
DHRDanaher Corp. -3.85%303.830.7%$644.33m
ABTAbbott Laboratories -1.47%118.810.8%$541.71m
ISRGIntuitive Surgical, Inc. -2.10%992.492.3%$519.72m
MDTMedtronic Plc -2.21%125.900.6%$451.27m
BDXBecton, Dickinson & Co. -0.62%249.881.0%$351.66m
ALGNAlign Technology, Inc. -3.38%677.326.3%$324.46m
BAXBaxter International, Inc. 0.22%80.751.8%$315.74m
HRCHill-Rom Holdings, Inc. 0.19%149.572.2%$312.56m
IDXXIDEXX Laboratories, Inc. -3.57%626.853.8%$298.98m
DXCMDexCom, Inc. -2.21%536.947.8%$289.83m
SYKStryker Corp. -2.12%267.691.3%$269.52m
BSXBoston Scientific Corp. -1.69%43.711.0%$256.32m
ZBHZimmer Biomet Holdings, Inc. -0.47%150.831.7%$244.56m
AAgilent Technologies, Inc. -3.86%159.961.6%$224.76m

Company Profile

Aethlon Medical, Inc. is a medical technology company, which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.